IOVANCE BIOTHERAPEUTICS, INC. Investment Owned, at Fair Value
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Investment Owned, at Fair Value of $179.26 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes
us-gaap:InvestmentOwnedAtFairValue · last filed 2018-11-06
- 2018-09-30: Investment Owned, at Fair Value $179.26M.
- 2018-06-30: Investment Owned, at Fair Value $110.02M.
- 2017-12-31: Investment Owned, at Fair Value $91.28M.
- 2017-06-30: Investment Owned, at Fair Value $90.92M.
| Period end | Investment Owned, at Fair Value |
|---|---|
| 2018-09-30 | $179.26M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $110.02M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $91.28M 10-Q · filed 2018-08-07 |
| 2017-06-30 | $90.92M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $90.41M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $90.40M 10-K · filed 2018-03-12 |
| 2016-09-30 | $175.04M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $90.35M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $90.22M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $90.06M 10-K · filed 2017-03-09 |
| 2015-09-30 | $99.94M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $99.78M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |